Harte-Hanks (HHS) Misses Q2 EPS by 391c
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $3.68 +1.94%
Financial Fact:
Operating income: -4.57M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Operating income: -4.57M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Harte-Hanks (NASDAQ: HHS) reported Q2 EPS of ($3.84), $3.91 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $45.03 million versus the consensus estimate of $47.5 million.
For earnings history and earnings-related data on Harte-Hanks (HHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- CoVolt Power files for proposed IPO
- Cytek faces $56M damages award in Beckman Coulter patent case
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
